期刊文献+

肺癌纵隔淋巴结转移规律的分析 被引量:9

Regulation of Mediastinal Lymph Nodes Metastasis in Patients with Lung Cancer
暂未订购
导出
摘要 目的:探讨肺癌纵隔淋巴结转移的规律与特点。方法:对358例肺癌行肺切除加淋巴结廓清术,对其中132例N2肺癌病例的281组转移性纵隔淋巴结进行临床病理分析。结果:两组以上N2转移占62.1%,跳跃式转移占12.1%,左侧肺癌N2转移发生率较高的依次为5、7、6组淋巴结,右侧肺癌N2转移发生率较高的依次为4、7、3组淋巴结;瘤体越大N2转移发生率越高,肺癌分化程度越差,N2转移发生率越高;病理类型不同,N2转移发生率分别为:小细胞癌80.0%、腺癌45.1%、大细胞癌33.3%、鳞癌24.0%。结论:对N2肺癌行广泛、全面的纵隔淋巴结清扫是十分必要的。 Objective:To investigate the rule and characteristics of mediastinal lymph nodes metastasis in lung cancer.Methods:358patients with lung cancer were performed pneu-monectomy and lymphadenectomy.Acquired281groups metastasis mediastinal lymph nodes were given clinicopathologic analysis in132cases N 2 lung cancer patients.Results:More than two groups N 2 metastasis was62.1%.Skipping metastasis was12.1%.The higher incidence rate of N 2 metasta sis in the left lung cancer decreased from fifth?seventh to sixth group lymph nodes,while it was from fourth?seventh to third group lymph nodes in the right lung cancer.The more volume,the lower differentiation of tumor,the higher incidence of N 2 metastasis.The incidence of N 2 metasta sis was different with different pathological type.The N 2 metastasis incidence of SCLC,adenocarcinoma,large cell lung cancer and squamous lung cancer was80.0%?45.1%?33.3%and24.0%re spectively.Conclusion:Exhaustive lymphadenectomy is necessary in N 2 lung cancer.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2002年第11期790-792,共3页 Chinese Journal of Clinical Oncology
关键词 肺肿瘤 纵隔淋巴结转移 清除术 临床分析 Lung tumor Mediastinal lymph nodes metastasis Lymphadenectomy
  • 相关文献

参考文献4

二级参考文献16

  • 1吴一龙,戎铁华,黄植蕃,杨名添,曾灿光,傅剑华.肺癌临床TNM与病理TNM分期一致性的探讨[J].中华肿瘤杂志,1994,16(3):211-213. 被引量:7
  • 2曲家骐,马富锦,黄文臣,候维平,史宁江.肺癌纵隔淋巴结转移及清除的必要性[J].中华胸心血管外科杂志,1995,11(3):151-153. 被引量:27
  • 31,Naruke T, Suemasu K, Ishikawa S, et al. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg,1978,76(6)∶832-839.
  • 42,Ayabe H, Tsuji H, Nakamura A. Evaluation of hilar and mediastinal lymph node metastases in resected cases of bronchogenic carcinoma. Jpn J Thorac Surg,1994,47(1)∶28-32.
  • 53,Riquet M, Hidden G, Debesse B. Direct lymphatic drainage of lung segments to the mediastinal nodes. J Thorac Cardiovasc Surg,1989,97(5)∶623-632.
  • 6Martini N,Flehinger BJ,Zaman MB. Results of resection in non-oat cell carcinoma ofthe lung with medastinal lymph node metastases. Ann Surg,1983,198(3)∶386-397.
  • 7Mountain CF. A new international staging system for lung cancer. Chest,1986,89(4suppl)∶225s-233s.
  • 8PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small celllung cancer:Systematic reviews and meta-analysis of individual patient data from ninerandomised controlled trials. Lancet,1998,352(9124)∶257-263.
  • 9Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lungcancer: a meta-analysis using updated data on individual patient from 52 randomisedclinical trials.BMJ,1995,311(7010)∶899-909.
  • 10van Velzen E,Snijder RJ,Brutel de la Riviere A, et al. Lymph node type as aprognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. Ann ThoracSurg,1997,63(5)∶1436-1440.

共引文献78

同被引文献69

引证文献9

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部